/nginx/o/2020/12/12/13525575t1hb431.jpg?fit=%2C&ssl=1 "Pfizer and BioNTech vaccine against Covid-19 approved for emergency use in the US – Abroad – News")
The emergency approval of the use provides an opportunity for a mass vaccination program in the United States. First of all, it is planned to vaccinate health care workers and residents of nursing homes.
–
“I approve the emergency use of the Pfizer-BioNTech Covid-19 vaccine to prevent Covid-19,” FDA Chief Scientist Denise Hinton wrote in a letter to a Pfizer executive.
–
“The FDA’s approval of the emergency use of the first Covid-19 vaccine is a significant milestone in the fight against this devastating pandemic, which has affected so many families in the United States and around the world,” said FDA Chief Steven Hahn.
–
The vaccine has been approved for use in people 16 years of age and older.
–
The vaccine was 95% effective in clinical trials with Pfizer.
–
The United States, which previously ordered 100 million doses of the vaccine, is expected to begin vaccination in the coming days. As two doses are needed per person, this order will be enough to vaccinate 50 million people.
— .
